The Endothelin B Receptor pipeline drugs market research report outlays comprehensive information on the Endothelin B Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Endothelin B Receptor pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, Cardiovascular, Central Nervous System, and Ophthalmology which include the indications Metastatic Melanoma, Glioblastoma Multiforme (GBM), Pulmonary Arterial Hypertension, Acute Ischemic Stroke, Alzheimer’s Disease, Hypoxic-Ischemic Encephalopathy, and Diabetic Retinopathy. It also reviews key players involved in Endothelin B Receptor targeted therapeutics development with respective active and dormant or discontinued products.
The Endothelin B Receptor pipeline targets constitutes close to 12 molecules. Out of which, approximately 12 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, and Discovery stages are 2, 1, 2, 1, 2, and 4 respectively.
Endothelin B Receptor overview
Endothelin receptor type B (EDNRB) is a G protein-coupled receptor that activates a phosphatidylinositol-calcium second messenger system. Its ligand, endothelin, consists of a family of three potent vasoactive peptides: ET1, ET2, and ET3. In melanocytic cells the EDNRB gene is regulated by the microphthalmia-associated transcription factor.
For a complete picture of Endothelin B Receptor’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.